QBNK has signed 2-year contract with global pharmaceutical company

Customer Case | Press Release

QBNK will supply DAM-platform QBank to one of the leading pharmaceutical companies with a global presence in over 60 markets.

A global pharmaceutical company has chosen QBank as platform for a substantial part of their market kommunicatons, including images, movies and presentations.

QBank will be connected to all of the client's approx. 200 websites as well as integrated with the client's assorted publishing systems and additional internal solutions. QBank will also act as the foundation of a new brand portal where the company will be presenting all information and digital material regarding all of the sub brands of the client.

"The fact that this company choses QBank as the platform to manage such a substantial part of their communication gives us confirmation that QBank can broaden its offer further," says Carl Petruson, CEO of QBNK in a comment.

The order value is set at 1,2 million SEK, where 70 % represents subscription revenues during 24 months and 30 % represents project and implementetion revenues. 50 % of the project revenue is debited at start-up and 50 % by final delivery.

 

About QBNK Holding AB (publ)

QBank's mission is to provide companies and government agencies cloud-based products and services in Digital Asset Management. The company develops their own products and supply them through partners for a provision. Clients are signed to subsrictions of 12, 24 or 36 months. The company has seen a profitable annual growth of 30 - 40% over the last four years.

The ticker symbol for the stock is: QBNK
ISIN code of the company's shares is: SE0007278726

For more information, please contact:

Carl Petruson, CEO
QBNK Holding AB (publ)
Tel: +46 8-459 99 90
e-mail: carl.petruson@qbank.se

Download PDF Download Press Release (Swedish)

Subscribe now

Don't miss the latest news from QBank.

Start your journey today

Book a demo with our sales team